Friday, May 1, 2026

Super Bowl vs. Olympic Games: How Athletes Are Balancing Sleep and Support in 2026

The 2026 Super Bowl's timing clashes with the Winter Olympics, leaving Team USA athletes torn between sleep and watching the game.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

Tag: security automation

AI Just Made Cybersecurity Easier with This No-Code Builder

Blink Ops launches a No-Code Security Agent Builder, allowing users to create custom security processes without coding skills.

Top News

- Our Sponsors Ad -

Follow us